Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.

Z. Paul Lorenc; Jeffrey M. Kenkel; Steven Fagien; Haideh Hirmand; Mark S. Nestor; Anthony P. Sclafani; Jonathan M. Sykes; Heidi A. Waldorf

doi:10.1177/1090820X13480479

Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.

Z. Paul Lorenc, Jeffrey M. Kenkel, Steven Fagien, Haideh Hirmand, Mark S. Nestor, Anthony P. Sclafani, Jonathan M. Sykes, Heidi A. Waldorf

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.

Original language	English (US)
Pages (from-to)	35S-40S
Journal	Unknown Journal
Volume	33
Issue number	1 Suppl
DOIs	https://doi.org/10.1177/1090820X13480479
State	Published - Mar 2013

ASJC Scopus subject areas

Surgery

Access to Document

10.1177/1090820X13480479

Cite this

@article{ff3b394d1c2d4e0f9db5d1be17824226,

title = "Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.",

abstract = "In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.",

author = "Lorenc, {Z. Paul} and Kenkel, {Jeffrey M.} and Steven Fagien and Haideh Hirmand and Nestor, {Mark S.} and Sclafani, {Anthony P.} and Sykes, {Jonathan M.} and Waldorf, {Heidi A.}",

year = "2013",

month = mar,

doi = "10.1177/1090820X13480479",

language = "English (US)",

volume = "33",

pages = "35S--40S",

journal = "Unknown Journal",

issn = "1744-165X",

publisher = "W.B. Saunders Ltd",

number = "1 Suppl",

}

TY - JOUR

T1 - Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.

AU - Lorenc, Z. Paul

AU - Kenkel, Jeffrey M.

AU - Fagien, Steven

AU - Hirmand, Haideh

AU - Nestor, Mark S.

AU - Sclafani, Anthony P.

AU - Sykes, Jonathan M.

AU - Waldorf, Heidi A.

PY - 2013/3

Y1 - 2013/3

N2 - In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.

AB - In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.

UR - http://www.scopus.com/inward/record.url?scp=84883046783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883046783&partnerID=8YFLogxK

U2 - 10.1177/1090820X13480479

DO - 10.1177/1090820X13480479

M3 - Article

C2 - 23515197

AN - SCOPUS:84883046783

SN - 1744-165X

VL - 33

SP - 35S-40S

JO - Unknown Journal

JF - Unknown Journal

IS - 1 Suppl

ER -

Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this